Immunic

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.

About IMUX

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.

CEO

Daniel Vitt

CEODaniel Vitt

Employees

Employees91

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2003

Founded2003

Employees

Employees91

IMUX Key Statistics

Market cap

87.35M

Market cap87.35M

Price-Earnings ratio

-0.93

Price-Earnings ratio-0.93

Dividend yield

—

Dividend yield—

Average volume

518.70K

Average volume518.70K

High today

$0.93

High today$0.93

Low today

$0.90

Low today$0.90

Open price

$0.91

Open price$0.91

Volume

445.47K

Volume445.47K

52 Week high

$2.11

52 Week high$2.11

52 Week low

$0.8319

52 Week low$0.8319

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.